marijuana stock news

Alkaline Water To Launch CBD Topicals Line, E-Commerce Platform

The Alkaline Water Company (NASDAQ: WTER) launched its own line of CBD topical products, including balms, bath salts, lotions, essential oils, and salves, all made with full-spectrum hemp under the brand name, A88CBD.

The company plans to launch a new e-commerce website dedicated solely to the sale of its topical CBD products. The company said the expected launch date of the e-commerce website will be Feb. 20.

“This is another major milestone for our company as we push towards becoming a national lifestyle brand,” said Ricky Wright, CEO of The Alkaline Water Company. “We have worked diligently over the past 24 months to develop the best CBD offerings in the marketplace and are thrilled to announce our hard work.

“The E-commerce launch is happening on the heels of a tremendous ECRM CBD Topical show. Our brick and mortar retail clients showed tremendous interest in our A88CBD™ Topicals at the show and we expect to receive orders immediately. We know that almost 50% of all shoppers will participate in E-commerce this year and we consider this platform, and our partnership with a modern full-service agency such as YouTech, to be a major driver for our 2020 CBD business.”


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$ATTBF Talks about VDL License and Technology

Abattis Maintains it is Still the Worldwide Exclusive Licensee to Certain VDL…

Beleave Inc. (BLEVF) Announces Consulting Agreement with Shaxon Enterprises

Beleave Announces Consulting Agreement with Shaxon Enterprises Beleave Inc. (CSE: BE) (OTCQX:…

Aurora Cannabis Inc. (ACB) to Host Third Quarter Fiscal Year 2021 Investor Conference Call

Aurora Cannabis to Host Third Quarter Fiscal Year 2021 Investor Conference Call…

AbbVie Inc. (ABBV) Presents Positive Investigational Navitoclax Combination Data

AbbVie Presents Positive Investigational Navitoclax Combination Data in Phase 2 REFINE Study…